Opens in a new tab

40 Year Old Pharmaceutical Manufacturing Business

Country
IndiaIndia
Listing ID
L#20210013
Target Price
$40,000,000
Revenue
$25,000,000
EBITDA
$3,000,000

Description

The company was founded in the district Punjab India, 1982 with a purpose of manufacturing Active Pharmaceutical Ingredients.

The company is an active pharmaceutical ingredient (API) manufacturing company that manufactures the raw materials for several leading companies of the pharma industry, who use these products for making medicines.

They supply products to companies such as Pfizer, Abbott, Cipla, Glenmark, Macleods, Aristo, etc.

The company is offerings range from Antibiotics, vitamins, anti-coagulants to ophthalmic products. Business is also audited by several organizations such as ISO, ZED and also GMP by regulatory bodies in India and overseas.

Research

Business is working on a patented technology for a recombinant protein which works on a novel targeted therapy and also assures no side effects. Currently, operations focus on high-end novel molecules.

Studies

Company is presently conducting experimental studies on stem cell rejuvenation therapies which also promise a future of medication without any side effects.

Biotechnology

The company is engaged in undertaking significant biotechnology research activities in the area of targeted human therapeutic proteins. Its current research work focuses on creating a novel drug, which while curing asthma and allergy patients can also work on mastocytosis and basophilic leukemia.

Team

The team is composed by 100 enlightened individuals, Chemists, Pharmacists, Biotechnologists, Quality controllers, R & D experts, Warehousing personnel.

Market: 65% India / 35% Rest of the World / Europe

Products: 25 OEM Products / Pharma Active Ingredients Raw Material

Most Sold: Antibiotics

Standards: ISO9001, EU Standards (No FDA)

Growth Rate: 20%+ / Year

Size: 100+ Employees

Management: Chemical Engineer Background

Financial: $25M Revenue / $3M EBITDA

Customers:

Basic Details

Listing ID
L#20210013
Country
India
City
Vadodara
Industry
Manufacturing
Deal Status
Available
Established
1989
Reason for Selling
Retirement
Target Price
$40,000,000
Revenue
$25,000,000
EBITDA
$3,000,000
Revenue Multiple
1.6x
EBITDA Multiple
13.33x

M&A Middle Market Advisory Deal Tombstones 2024

AdvisorDeals
MergersCorp M&A International21
Keith Advisory17
GCG9
JP Morgan41
Jefferies23
Lazard26
Goldman Sachs30

Businesses for Sale

Similar Opportunities

KazakhstanKazakhstanManufacturingL#20261174

Central Asian Chlor-Alkali & Chemicals Manufacturing Platform

The proposed project entails the development of a state-of-the-art, vertically integrated chlor-alkali and downstream specialty chemical manufacturing cluster in Kazakhstan. Capitalizing on abundant domestic salt reserves, competitive operating fundamentals, and strategic Eurasian logistics corridors, the project is structured to substitute…

Target Price
$1,000,000,000
Revenue
$620,000,000
EBITDA
$186,000,000
United StatesUnited StatesManufacturingL#20261103

American Leading Life Sciences Research Services Platform

A leading independent multi-omics service providers in the Americas. The Company provides a comprehensive portfolio of next-generation sequencing (NGS), proteomics, metabolomics, epigenomics, and bioinformatics solutions to research institutions, hospitals, biotechnology companies, and pharmaceutical clients across North and South America. Following…

Target Price
$44,000,000
Revenue
$57,000,000
EBITDA
$3,700,000